These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22248910)

  • 1. Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps.
    Choi KE; Kim MJ; Lee JH; Lee JS; Lee JH; Choe YH
    Digestion; 2012; 85(3):179-84. PubMed ID: 22248910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of inflammatory fibroid polyp of the esophagogastric junction.
    Yamane T; Uchiyama K; Ishii T; Ishii H; Takizawa R; Omura M; Fujise K; Tajiri H
    Dig Endosc; 2009 Apr; 21(2):97-100. PubMed ID: 19691782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of an inflammatory esophagogastric polyp.
    Hirasaki S; Koide N; Suzuki S; Nishina K
    Intern Med; 2011; 50(18):2047-8. PubMed ID: 21921395
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete disappearance of an esophagogastric polyp with concurrent early-stage adenocarcinoma after administration of a proton pump inhibitor.
    Yoshida T; Shimizu Y; Hirota J; Ono Y; Nakagawa M; Ono S; Nakagawa S; Kato M; Asaka M
    Endoscopy; 2010; 42 Suppl 2():E176-7. PubMed ID: 20560121
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pseudomalignant endoscopic appearance in hyperplastic polyp at esophagogastric junction: case report].
    Salihoun M; Stock N; Alexandre JL; Rioux N; Bretagne JF; Heresbach D
    Gastroenterol Clin Biol; 2008 Apr; 32(4):370-3. PubMed ID: 18400434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory polyp-fold complex in children.
    Bishop PR; Nowicki MJ; Subramony C; Parker PH
    J Clin Gastroenterol; 2002 Mar; 34(3):229-32. PubMed ID: 11873101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polyps esophageal cardio-conversion in children: causes, clinical picture, management and prognosis of tactics].
    Sergeeva TN
    Eksp Klin Gastroenterol; 2009; (5):124-9. PubMed ID: 20201314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An admixture type of hyperplastic polyp at the esophagogastric junction.
    Hayashi T; Shikuwa S; Isomoto H; Yamaguchi N; Ohnita K; Inoue N; Nishiyama H; Fukuda E; Mizuta Y; Kohno S
    Endoscopy; 2008 Sep; 40 Suppl 2():E66-7. PubMed ID: 18633911
    [No Abstract]   [Full Text] [Related]  

  • 10. Two hyperplastic esophagogastric polyps in a child with neurofibromatosis type 1 (NF-1).
    Grynspan D; Lukacik M; Madani S; Poulik J
    Pediatr Dev Pathol; 2008; 11(3):235-8. PubMed ID: 17990926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
    Jalving M; Koornstra JJ; Wesseling J; Boezen HM; DE Jong S; Kleibeuker JH
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1341-8. PubMed ID: 17059515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomalignant erosion in hyperplastic polyp at esophago-gastric junction.
    Honda H; Kume K; Murakami H; Yamasaki T; Yoshikawa I; Otsuki M
    J Gastroenterol Hepatol; 2005 May; 20(5):800-1. PubMed ID: 15854002
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy and safety of argon plasma coagulation (APC) in the management of polyp remnants in stomach and colon.
    Neneman B; Gasiorowska A; Małecka-Panas E
    Adv Med Sci; 2006; 51():88-93. PubMed ID: 17357283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory esophagogastric polyp and fold in an adolescent.
    Kato S; Ozawa A; Shibuya H; Nakagawa H; Naganuma H
    Acta Paediatr Jpn; 1993 Feb; 35(1):53-6. PubMed ID: 8460546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.
    Emerson CR; Marzella N
    Clin Ther; 2010 Aug; 32(9):1578-96. PubMed ID: 20974316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to lansoprazole with tolerance to other proton pump inhibitors: does cross-reactivity between proton pump inhibitors really exist?
    Karabacak E; Kutlu A; Aydin E; Ozturk S
    Allergol Immunopathol (Madr); 2013; 41(2):136-7. PubMed ID: 23137870
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual Endoscopic Findings in Children: Esophageal and Gastric Polyps: Three Cases Report.
    Diaconescu S; Miron I; Gimiga N; Olaru C; Ioniuc I; Ciongradi I; Sarbu I; Stefanescu G
    Medicine (Baltimore); 2016 Jan; 95(3):e2539. PubMed ID: 26817898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile of six months lansoprozole treatment in children.
    Eren M; Yıldırım SH; Sivrikoz IA
    Indian J Gastroenterol; 2010 Nov; 29(6):247-8. PubMed ID: 21221882
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive fundic gland polyposis in a patient receiving protracted proton-pump inhibitor medication.
    Rubio CA; Befrits R; Osterberg J; Ohd J; Miller ML; Ramel S
    Anticancer Res; 2010 Jan; 30(1):261-3. PubMed ID: 20150645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of polyps on outcomes after endoscopic sinus surgery.
    Bhattacharyya N
    Laryngoscope; 2007 Oct; 117(10):1834-8. PubMed ID: 17690616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.